SE462163B - 8-/4-/4-(1-oxo-1,2-bensisotiazol-3-yl)-1-piperazinyl/butyl/-8-azaspiro/4,5/dekan-7,9-dion, farmaceutisk beredning innehaallande naemnda foerening samt foerfarande foer framstaellning daerav - Google Patents

8-/4-/4-(1-oxo-1,2-bensisotiazol-3-yl)-1-piperazinyl/butyl/-8-azaspiro/4,5/dekan-7,9-dion, farmaceutisk beredning innehaallande naemnda foerening samt foerfarande foer framstaellning daerav

Info

Publication number
SE462163B
SE462163B SE8601883A SE8601883A SE462163B SE 462163 B SE462163 B SE 462163B SE 8601883 A SE8601883 A SE 8601883A SE 8601883 A SE8601883 A SE 8601883A SE 462163 B SE462163 B SE 462163B
Authority
SE
Sweden
Prior art keywords
compound
azaspiro
piperazinyl
oxo
butyl
Prior art date
Application number
SE8601883A
Other languages
English (en)
Swedish (sv)
Other versions
SE8601883D0 (sv
SE8601883L (sv
Inventor
J P Yevich
Jr W G Lobeck
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8601883D0 publication Critical patent/SE8601883D0/xx
Publication of SE8601883L publication Critical patent/SE8601883L/xx
Publication of SE462163B publication Critical patent/SE462163B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8601883A 1985-04-24 1986-04-23 8-/4-/4-(1-oxo-1,2-bensisotiazol-3-yl)-1-piperazinyl/butyl/-8-azaspiro/4,5/dekan-7,9-dion, farmaceutisk beredning innehaallande naemnda foerening samt foerfarande foer framstaellning daerav SE462163B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/726,449 US4656173A (en) 1985-04-24 1985-04-24 Antipsychotic benzisothiazole S-oxide compound

Publications (3)

Publication Number Publication Date
SE8601883D0 SE8601883D0 (sv) 1986-04-23
SE8601883L SE8601883L (sv) 1986-10-25
SE462163B true SE462163B (sv) 1990-05-14

Family

ID=24918649

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8601883A SE462163B (sv) 1985-04-24 1986-04-23 8-/4-/4-(1-oxo-1,2-bensisotiazol-3-yl)-1-piperazinyl/butyl/-8-azaspiro/4,5/dekan-7,9-dion, farmaceutisk beredning innehaallande naemnda foerening samt foerfarande foer framstaellning daerav

Country Status (26)

Country Link
US (1) US4656173A (fi)
JP (1) JPH0764842B2 (fi)
KR (1) KR900000372B1 (fi)
CN (1) CN1017528B (fi)
AT (1) AT394719B (fi)
AU (1) AU592787B2 (fi)
BE (1) BE904662A (fi)
CA (1) CA1247102A (fi)
CH (1) CH666034A5 (fi)
DE (1) DE3613739C2 (fi)
DK (1) DK187686A (fi)
EG (1) EG18002A (fi)
ES (1) ES8708228A1 (fi)
FI (1) FI84604C (fi)
FR (1) FR2581064B1 (fi)
GB (1) GB2174393B (fi)
GR (1) GR861063B (fi)
HU (1) HU195654B (fi)
IE (1) IE59182B1 (fi)
IT (1) IT1208600B (fi)
LU (1) LU86405A1 (fi)
MY (1) MY102041A (fi)
NL (1) NL8601043A (fi)
PT (1) PT82450B (fi)
SE (1) SE462163B (fi)
ZA (1) ZA861531B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
WO1990002552A1 (en) * 1988-09-16 1990-03-22 Pfizer Inc. Antipsychotic 4-[4-(3-benzisothiazolyl)-1-piperazinyl]butyl bridged bicyclic imides
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
CH582699A5 (fi) * 1973-03-26 1976-12-15 Sandoz Ag
AT342057B (de) * 1974-04-25 1978-03-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen 3-piperazino-isochinolinen und deren salzen
FI753625A (fi) * 1975-01-06 1976-07-07 Spofa Vereinigte Pharma Werke
JPS51144735A (en) * 1975-06-06 1976-12-13 Nippon Nohyaku Co Ltd A remedy for hepatic failure
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives

Also Published As

Publication number Publication date
HUT42088A (en) 1987-06-29
CN86102742A (zh) 1987-02-04
PT82450B (pt) 1988-11-30
IT8620187A0 (it) 1986-04-23
ATA110486A (de) 1991-11-15
CN1017528B (zh) 1992-07-22
DK187686D0 (da) 1986-04-23
IE59182B1 (en) 1994-01-26
IE861083L (en) 1986-10-24
CA1247102A (en) 1988-12-20
ZA861531B (en) 1986-10-29
FI861668A (fi) 1986-10-25
JPS61251683A (ja) 1986-11-08
GB2174393B (en) 1989-02-01
MY102041A (en) 1992-02-29
NL8601043A (nl) 1986-11-17
BE904662A (fr) 1986-10-23
IT1208600B (it) 1989-07-10
AU5612186A (en) 1986-10-30
KR900000372B1 (ko) 1990-01-25
AU592787B2 (en) 1990-01-25
GB8609932D0 (en) 1986-05-29
CH666034A5 (de) 1988-06-30
DE3613739C2 (de) 1993-12-09
ES8708228A1 (es) 1987-10-01
PT82450A (en) 1986-05-01
HU195654B (en) 1988-06-28
LU86405A1 (fr) 1986-11-05
FR2581064B1 (fr) 1988-09-16
SE8601883D0 (sv) 1986-04-23
FR2581064A1 (fr) 1986-10-31
GB2174393A (en) 1986-11-05
DE3613739A1 (de) 1986-11-20
FI84604C (fi) 1991-12-27
US4656173A (en) 1987-04-07
FI861668A0 (fi) 1986-04-21
AT394719B (de) 1992-06-10
GR861063B (en) 1986-09-01
DK187686A (da) 1986-10-25
FI84604B (fi) 1991-09-13
JPH0764842B2 (ja) 1995-07-12
KR860008174A (ko) 1986-11-12
ES554284A0 (es) 1987-10-01
EG18002A (en) 1991-08-30
SE8601883L (sv) 1986-10-25

Similar Documents

Publication Publication Date Title
US6919355B2 (en) Amide derivatives as NMDA receptor antagonists
US5021421A (en) 2-(1-Piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
WO1993022298A1 (en) Oxazolidine derivative and pharmaceutically acceptable salt thereof
WO2000006550A1 (fr) Composes phenylazole, procede de production desdits composes et medicaments pour le traitement de l'hyperlipidemie
KR20030019555A (ko) 프로판-1,3-디온 유도체
JPH0517457A (ja) ベンズイソチアゾールおよびベンズイソキサゾールピペラジン誘導体
JPH01249769A (ja) 向精神性ヘテロビシクロアルキルピペラジン誘導体
US8653069B2 (en) Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
EP2576536B1 (en) Haematopoietic-prostaglandin d2 synthase inhibitors
CN107793408B (zh) 哌啶氨基衍生物及其治疗精神分裂症的应用
MXPA06014131A (es) Derivado de propano-1,3-diona o su sal.
SE462163B (sv) 8-/4-/4-(1-oxo-1,2-bensisotiazol-3-yl)-1-piperazinyl/butyl/-8-azaspiro/4,5/dekan-7,9-dion, farmaceutisk beredning innehaallande naemnda foerening samt foerfarande foer framstaellning daerav
EP1400515B1 (en) Cyclic diamine compound having five-membered cyclic group
KR20200116912A (ko) 카르복실산기를 포함하는 질소-함유 벤조헤테로시클 화합물, 이의 제조 방법 및 이의 용도
KR940000829B1 (ko) 항정신병성 융합-환의 피리디닐 피페라진 유도체의 제조방법
FI76794B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spirotiazolidindionderivat.
US11993603B2 (en) Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and application thereof
US7371769B2 (en) Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
US20220048914A1 (en) Preparation for 6-amino-1h-pyrazolo[3,4-d]pyrimidine-based jak kinase inhibitor and application thereof
WO2006061373A2 (en) Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
US20060122177A1 (en) Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
JPH0641079A (ja) ピリジン誘導体
HU187332B (en) Process for preparing 9-/3-/3,5-cys-dimethyil-piperazinyl/-propyl/-carbazole, its salts and the solvates of the salts
WO2014024993A1 (ja) ピぺラジン誘導体およびその用途

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8601883-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8601883-5

Format of ref document f/p: F